Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance (Q34471934)

2 August 2017

title

Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance (English)

1 reference

2 August 2017

0 references

Alessandra Dei Cas

10

0 references

Marco Metra

object named as

Marco Metra

9

0 references

author name string

Valentina Spigoni

1

1 reference

2 August 2017

Angela Picconi

2

1 reference

2 August 2017

Monia Cito

3

1 reference

2 August 2017

Valentina Ridolfi

4

1 reference

2 August 2017

Sabrina Bonomini

5

1 reference

2 August 2017

Chiara Casali

6

1 reference

2 August 2017

Ivana Zavaroni

7

1 reference

2 August 2017

Luigi Gnudi

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

5 November 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

7

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

e48283

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

copyright license

start time

5 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Endothelial precursors in vascular repair

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Pioglitazone suppresses the lipopolysaccharide-induced production of inflammatory factors in mouse macrophages by inactivating NF-kappaB.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Vascular effects of PPARgamma activators - from bench to bedside

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Working hypothesis to redefine endothelial progenitor cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic action

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Development of a sensitive multi-well colorimetric assay for active NFkappaB

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Isolation of putative progenitor endothelial cells for angiogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3489677

Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta

6 July 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: a randomized prospective study using intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Effect of pioglitazone on endothelial function in impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Glucose tolerance is negatively associated with circulating progenitor cell levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Blood monocytes mimic endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Antiinflammatory and antiarteriosclerotic effects of pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Pioglitazone reduces tumor necrosis factor-alpha serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0048283

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

21 January 2018

1 reference

12 December 2020

Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1

1 reference

12 December 2020

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia

1 reference

12 December 2020

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

1 reference

12 December 2020

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

1 reference

12 December 2020

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

12 December 2020

The American Diabetes Association's Clinical Practice Recommendations and the developing world

1 reference

12 December 2020

Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells

1 reference

12 December 2020

Circulating CD34 cells, metabolic syndrome, and cardiovascular risk

1 reference

12 December 2020

Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus

1 reference

12 December 2020

The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells

1 reference

12 December 2020

Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0048283

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference